Computomics
Bioinformatics · Biotechnology
$6.8Mlatest round · Series B · Aug 2026 · 2 mo ago
1backers · High-Tech Gründerfonds
$4.5Mgrants · 12 grants · CORDIS
10+team · employees, estimated range
Key facts
These are the key facts about Computomics on Alion as of Nov 13, 2026. Computomics is headquartered in Stuttgart, Germany. It was founded in 2012. The latest round is Series B of $6.8M, announced in 2026.
- Headquarters
- Stuttgart, GermanyAlion company profile, updated Oct 5, 2026
- Founded
- 2012Alion company profile, updated Oct 5, 2026
- Employees
- 10+Alion company profile, an estimated range
- Total raised
- $6.8MSum of 1 equity round Alion knows
- Latest round
- Series B · $6.8M · Aug 18, 2026Press report · eu-startups.com
Official records
Funding and backers
Total raised
$6.8M
13 rounds on record
Latest round
$6.8M
Series B · Aug 2026 · 2 mo ago
Team
11-50
employees, estimated range
Grants
$4.5M
12 grants · CORDIS
Backers
1
High-Tech Gründerfonds
The money's age
Fresh money
2 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 1
Won a grant $298k · CORDIS
Aug 18
Raised a round Series B $6.8M · EU-Startups
Jun 1
Won a grant $142k · CORDIS
Nov 1, 2024
Won a grant $267k · CORDIS
Apr 1, 2023
Won a grant $140k · CORDIS
Feb 1, 2023
Won a grant $131k · CORDIS
Jan 1, 2023
Won a grant $2.6M · CORDIS
Apr 15, 2022
Won a grant $179k · CORDIS
Oct 1, 2021
Won a grant $294k · CORDIS
Jun 1, 2021
Won a grant $134k · CORDIS
Sep 1, 2020
Won a grant $106k · CORDIS
Feb 1, 2020
Won a grant $142k · CORDIS
Dec 1, 2019
Won a grant $54k · CORDIS
2012
Founded
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Oct 2026 | $298k | — | CORDIS |
| Series B | Aug 2026 | $6.8M | — | EU-Startups |
| Grant | Jun 2026 | $142k | — | CORDIS |
| Grant | Nov 2024 | $267k | — | CORDIS |
| Grant | Apr 2023 | $140k | — | CORDIS |
| Grant | Feb 2023 | $131k | — | CORDIS |
| Grant | Jan 2023 | $2.6M | — | CORDIS |
| Grant | Apr 2022 | $179k | — | CORDIS |
| Grant | Oct 2021 | $294k | — | CORDIS |
| Grant | Jun 2021 | $134k | — | CORDIS |
| Grant | Sep 2020 | $106k | — | CORDIS |
| Grant | Feb 2020 | $142k | — | CORDIS |
| Grant | Dec 2019 | $54k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | Computomics GmbH | its site |
| Registered | 5 Oct 2012 |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Unlocking the full potential of chemoproteomics to accelerate the discovery of new small molecules that can change the course of disease.
About knowing01 knowing01 GmbH is a Munich-based life science software and analytics company founded in 2020. We help researchers in…
Tesorai connects mass spectrometry search, conversational analysis, and curated public datasets in one platform — from raw data to stronger…
What if ageing is reversible?. Ageing is usually understood as the progressive accumulation of biological damage.
Protai leverages proteomics and AI to accelerate drug discovery, enabling faster identification of novel therapeutic targets and biomarkers.
Endogene.bio generates high-resolution data from menstrual blood to accelerate disease understanding, patient stratification, and…
Financials
Total raised
$11.3M
Latest round
Grant
Funding rounds
13
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Grant | 2026 | $298k | Details |
| Series B | 2026 | $6.8M | Details |
| Grant | 2026 | $142k | Details |
| Grant | 2024 | $267k | Details |
| Grant | 2023 | $140k | Details |
| Grant | 2023 | $131k | Details |
| Grant | 2023 | $2.6M | Details |
| Grant | 2022 | $179k | Details |
| Grant | 2021 | $294k | Details |
| Grant | 2021 | $134k | Details |
| Grant | 2020 | $106k | Details |
| Grant | 2020 | $142k | Details |
| Grant | 2019 | $54k | Details |
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
High-Tech GründerfondsVia a fund
517 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
News
Deshalb wurde in Computomics investiert
Das Tübinger Unternehmen Computomics hat mehr als sechs Millionen Euro an frischem Kapital von Investoren und Förderprogrammen bekommen. Damit will Computomics den Einsatz von künstlicher Intelligenz in der Pflanzenzüchtung weiterentwickeln. SWR-Reporter
Read more
Report
Gravis Robotics erhält 200 Millionen - Computomicsbekommt 6,3 Millionen - Dash0 kauft Polar Signals
+++ #DealMonitor +++ Unicorn-Investment: Gravis Robotics erhält 200 Millionen +++ Computomicsbekommt 6,3 Millionen +++ Unicorn Dash0 kauft Polar Signals +++ get.de Partners setzt auf GoLeasy +++ accompio übernimmt techbold +++
Read more
Report
Germany's Computomics secures €6.3 million to help crop breeders stay ahead of heat and drought
Computomics, a Tübingen-based BioTech research company, has raised €6.3 million in a Series B round to scale commercial delivery of its climate-smart breeding platform, as heat and drought take an increasing toll on European harvests. The round was led by
Read more
Report
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Stuttgart
Germany
HQ
How to cite this page
Alion, "Computomics: key facts", as of Nov 13, 2026. https://alion.io/company/computomics
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0